MoneyWorks4Me

Sun Pharmaceutical Industries informs about press release

07 Apr 2025 Evaluate
Sun Pharmaceutical Industries has informed that it enclosed a copy of the Press Release about Sun Pharma introducing a novel class of drug, Fexuclue®(Fexuprazan) in India for the treatment of Erosive Esophagitis, which shall be released after this intimation.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1782.00
Dr. Reddys Labs. 1208.00
Cipla 1334.00
Lupin 2010.00
Zydus Lifesciences 1138.50
View more..